Rozenn Brillet

1.3k total citations
25 papers, 986 citations indexed

About

Rozenn Brillet is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Rozenn Brillet has authored 25 papers receiving a total of 986 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hepatology, 15 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in Rozenn Brillet's work include Hepatitis C virus research (17 papers), Hepatitis B Virus Studies (14 papers) and Liver Disease Diagnosis and Treatment (7 papers). Rozenn Brillet is often cited by papers focused on Hepatitis C virus research (17 papers), Hepatitis B Virus Studies (14 papers) and Liver Disease Diagnosis and Treatment (7 papers). Rozenn Brillet collaborates with scholars based in France, Switzerland and Italy. Rozenn Brillet's co-authors include Jean–Michel Pawlotsky, Stéphane Chevaliez, Abdelhakim Ahmed‐Belkacem, Magali Bouvier‐Alias, Coralie Pallier, Nazim Ahnou, Christophe Hézode, Daniel Dhumeaux, Wei Yi and Ahcène Boumendjel and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Gastroenterology.

In The Last Decade

Rozenn Brillet

25 papers receiving 959 citations

Peers

Rozenn Brillet

HEPAT

EPIDE

Coralie Pallier France

Li‐Tain Yeh United States

Romy Zemel Israel

Abdelhakim Ahmed‐Belkacem France

Jessica Wagoner United States

Chunlan Feng China

Michel Garneau Canada

Syed Naqui Kazim India

Jinfa Du United States

Michael H. Serrano‐Wu United States

Coralie Pallier France

Rozenn Brillet

298 ×0.6

HEPAT

309 ×0.7

EPIDE

182 ×0.8

136 ×0.8

66 ×0.5

Citations per year, relative to Rozenn Brillet Rozenn Brillet (= 1×) peers Coralie Pallier

Countries citing papers authored by Rozenn Brillet

Since Specialization

Citations

This map shows the geographic impact of Rozenn Brillet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rozenn Brillet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rozenn Brillet more than expected).

Fields of papers citing papers by Rozenn Brillet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rozenn Brillet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rozenn Brillet. The network helps show where Rozenn Brillet may publish in the future.

Co-authorship network of co-authors of Rozenn Brillet

This figure shows the co-authorship network connecting the top 25 collaborators of Rozenn Brillet. A scholar is included among the top collaborators of Rozenn Brillet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rozenn Brillet. Rozenn Brillet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bartier, S., Rozenn Brillet, Công Trung Nguyễn, et al.. (2022). Desloratadine, an FDA-approved cationic amphiphilic drug, inhibits SARS-CoV-2 infection in cell culture and primary human nasal epithelial cells by blocking viral entry. Scientific Reports. 12(1). 21053–21053. 10 indexed citations

Fourati, Slim, Christophe Rodriguez, Alexandre Soulier, et al.. (2020). Fitness‐associated substitutions following failure of direct‐acting antivirals assessed by deep sequencing of full‐length hepatitis C virus genomes. Alimentary Pharmacology & Therapeutics. 52(10). 1583–1591. 5 indexed citations

Ruiz, Isaac, Quentin Nevers, Eva Hernández, et al.. (2020). MK-571, a Cysteinyl Leukotriene Receptor 1 Antagonist, Inhibits Hepatitis C Virus Replication. Antimicrobial Agents and Chemotherapy. 64(6). 7 indexed citations

Panel, Mathieu, Isaac Ruiz, Rozenn Brillet, et al.. (2019). Small-Molecule Inhibitors of Cyclophilins Block Opening of the Mitochondrial Permeability Transition Pore and Protect Mice From Hepatic Ischemia/Reperfusion Injury. Gastroenterology. 157(5). 1368–1382. 67 indexed citations

Ahmed‐Belkacem, Abdelhakim, Alessandra Nurisso, Wei Yi, et al.. (2016). New pseudodimeric aurones as palm pocket inhibitors of Hepatitis C virus RNA-dependent RNA polymerase. European Journal of Medicinal Chemistry. 115. 217–229. 21 indexed citations

Ahmed‐Belkacem, Abdelhakim, Lionel Colliandre, Nazim Ahnou, et al.. (2016). Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities. Nature Communications. 7(1). 12777–12777. 67 indexed citations

Ahmed‐Belkacem, Abdelhakim, Wei Yi, Romain Haudecoeur, et al.. (2014). B-ring modified aurones as promising allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase. European Journal of Medicinal Chemistry. 80. 579–592. 46 indexed citations

Ahmed‐Belkacem, Abdelhakim, Jean‐François Guichou, Rozenn Brillet, et al.. (2014). Inhibition of RNA binding to hepatitis C virus RNA-dependent RNA polymerase: a new mechanism for antiviral intervention. Nucleic Acids Research. 42(14). 9399–9409. 38 indexed citations

Chevaliez, Stéphane, Magali Bouvier‐Alias, Rozenn Brillet, & Jean–Michel Pawlotsky. (2009). Hepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical Practice. PLoS ONE. 4(12). e8209–e8209. 95 indexed citations

10.

Pallier, Coralie, Christophe Rodriguez, Rozenn Brillet, et al.. (2008). Complex dynamics of hepatitis B virus resistance to adefovir†. Hepatology. 49(1). 50–59. 29 indexed citations

11.

Chevaliez, Stéphane, et al.. (2008). 724 OUTBREAK OF A NEW HEPATITIS C VIRUS SUBTYPE (SUBTYPE 1M) IN A HEMODIALYSIS UNIT: HOW NEW HCV GENOTYPES START THEIR SPREAD. Journal of Hepatology. 48. S270–S271. 1 indexed citations

12.

Brillet, Rozenn, François Pénin, Christophe Hézode, et al.. (2007). The Nonstructural 5A Protein of Hepatitis C Virus Genotype 1b Does Not Contain an Interferon Sensitivity–Determining Region. The Journal of Infectious Diseases. 195(3). 432–441. 21 indexed citations

13.

Hézode, Christophe, Stéphane Chevaliez, Magali Bouvier‐Alias, et al.. (2007). Efficacy and safety of adefovir dipivoxil 20mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10mg daily. Journal of Hepatology. 46(5). 791–796. 26 indexed citations

14.

Chevaliez, Stéphane, Rozenn Brillet, Ester Lázaro, Christophe Hézode, & Jean–Michel Pawlotsky. (2007). Analysis of Ribavirin Mutagenicity in Human Hepatitis C Virus Infection. Journal of Virology. 81(14). 7732–7741. 67 indexed citations

15.

Chevaliez, Stéphane, Magali Bouvier‐Alias, Rozenn Brillet, & Jean–Michel Pawlotsky. (2007). Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction–based method. Hepatology. 46(1). 22–31. 98 indexed citations

16.

Pallier, C., et al.. (2007). [55] COMPLEX DYNAMICS OF HEPATITIS B VIRUS RESISTANCE TO ADEFOVIR DIPIVOXIL. Journal of Hepatology. 46. S26–S26. 12 indexed citations

17.

Chevaliez, Stéphane, Rozenn Brillet, C. Hézode, Daniel Dhumeaux, & Jean–Michel Pawlotsky. (2006). P.228 Assessment of ribavirin mutagenic properties in vivo and the influence of interferon alpha-induced reduction of hepatitis C virus RNA load upon therapy. Journal of Clinical Virology. 36. S132–S132. 3 indexed citations

18.

Chevaliez, Stéphane, Dominique Challine, Rozenn Brillet, & Jean–Michel Pawlotsky. (2006). 47 Full-length preS1-preS2-HBs antigen (HBsAg) sequence analysis of HBV surface mutants in hbv DNA-positive organ, tissue and cell donors with various HBV serological profiles. Journal of Hepatology. 44. S22–S22. 1 indexed citations

19.

Pawlotsky, Jean–Michel, Rozenn Brillet, C. Hézode, & Daniel Dhumeaux. (2004). 62 Is ribavirin antiviral effect in humans mediated by mutagenic properties resulting in error catastrophe?. Journal of Hepatology. 40. 23–23. 4 indexed citations

20.

Soulier, Alexandre, Rozenn Brillet, Joliette Coste, et al.. (2002). Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro. Journal of Virology. 76(16). 8189–8199. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact